Načítá se...
tPA for Acute Ischemic Stroke and Its Controversies: A Review
BACKGROUND AND PURPOSE: Although neurologists consider intravenous tissue plasminogen activator (tPA) to be standard of care in the treatment of patients with acute ischemic stroke, its use remains contentious within the broader medical community, and particularly among emergency physicians. Why mig...
Uloženo v:
| Vydáno v: | Neurohospitalist |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900654/ https://ncbi.nlm.nih.gov/pubmed/31839858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941874419838961 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|